Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Arrhythmias

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    August 2026
  1. WACHTER R, Haag P, Uhe T, Bacak M, et al
    Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.
    Lancet. 2026 Aug 30:S0140-6736(26)01558-8. doi: 10.1016/S0140-6736(26)01558.
    PubMed     Abstract available


  2. SEGAN L, Kistler PM
    Rethinking success after atrial fibrillation ablation: when sham is more than a placebo.
    Lancet. 2026 Aug 30:S0140-6736(26)01651-X. doi: 10.1016/S0140-6736(26)01651.
    PubMed    


    July 2026
  3. LIP GYH, Kuzma L
    Combination antithrombotic therapy in atrial fibrillation after coronary interventions: shorter duration, more safety?
    Lancet. 2026 Jul 15:S0140-6736(26)00747-6. doi: 10.1016/S0140-6736(26)00747.
    PubMed    


  4. SOTOMI Y, Kozuma K, Higuchi Y, Nakazawa G, et al
    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.
    Lancet. 2026 Jul 15:S0140-6736(26)00665-3. doi: 10.1016/S0140-6736(26)00665.
    PubMed     Abstract available


    March 2026
  5. LANE DA, Andrade JG, Arbelo E, Boriani G, et al
    Atrial fibrillation.
    Lancet. 2026;407:1000-1013.
    PubMed     Abstract available


    January 2026
  6. KELSHIKER MA, Bachtiger P, Petri CF, Nakhare S, et al
    Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial.
    Lancet. 2026 Jan 28:S0140-6736(25)02156-7. doi: 10.1016/S0140-6736(25)02156.
    PubMed     Abstract available


    June 2025
  7. ZIAI WC, Tsivgoulis G
    Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better swift than sorry.
    Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676.
    PubMed    


  8. DEHBI HM, Fischer U, Asberg S, Milling TJ, et al
    Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
    Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439.
    PubMed     Abstract available


    February 2025
  9. SALMAN RA, Shoamanesh A
    Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage.
    Lancet. 2025 Feb 26:S0140-6736(25)00366-6. doi: 10.1016/S0140-6736(25)00366.
    PubMed    


  10. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
    Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
    PubMed     Abstract available


    October 2024
  11. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
    Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
    Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
    PubMed     Abstract available


  12. SANDSET EC, de Sousa DA
    Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
    Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
    PubMed    


    September 2024
  13. PREVEL R, Boyer A, Gruson D, Orieux A, et al
    Catheter ablation for atrial fibrillation, atrio-oesophageal fistula, cerebral air embolism, and hyperbaric oxygen therapy.
    Lancet. 2024;404:1051-1052.
    PubMed    


    November 2023
  14. HEERSPINK HJL, Kiyosue A, Wheeler DC, Lin M, et al
    Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
    Lancet. 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230.
    PubMed     Abstract available


    September 2023
  15. FUJIMOTO Y, Iwasaki YK, Asai K
    Pericardial-oesophageal fistula after ablation for atrial fibrillation.
    Lancet. 2023;402:882.
    PubMed    


    August 2023
  16. WILKOFF BL, Filippatos G, Leclercq C, Gold MR, et al
    Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
    Lancet. 2023 Aug 24:S0140-6736(23)00912-1. doi: 10.1016/S0140-6736(23)00912.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum